Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.594
Filtrar
Adicionar filtros

Intervalo de ano
1.
Medical Science ; 26(129), 2022.
Artigo em Inglês | Web of Science | ID: covidwho-2207166

RESUMO

Coronavirus disease has a wide range of symptoms, from asymptomatic infection to critical illness, which may even lead to death. Fatigue is the most prevalent symptom in COVID patients during and after the acute phase of the disease. Fatigue in COVID patients still with unknown etiology. This crosssectional study used data from KSMC hospital records and direct interviews with patients affected by chronic fatigue following confirmed COVID. Data were analyzed using SPSS V24 and multiple regression analysis. Pearson correlation, chi square test were used in the analysis process. Our results found that vaccination status is strongly affecting chalder fatigue scale;also age, comorbidities and COVID severity affect the scale. Comorbidity was found to be high in older participants;also higher comorbidities associated with increased disease severity.

2.
Research Journal of Pharmacy and Technology ; 15(11):5132-5138, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-2207042

RESUMO

Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and antioxidant effects, upregulate angiotensin-converting enzyme 2 (ACE2) receptors, which happen to be SARS-CoV-2's gateway into cells. This study aims to analyse the effects of Fenofibrate in comparison to Statins and a control group in patients with COVID-19. This is a retrospective open blind observational study of cohort of 300 patients experienced COVID-19 (symptoms' severity varied between patients). The participants were divided into three cohorts;a control group received standard COVID-19 treatment (n=100);a second group (n=100) of patients who were on Statins, in addition they received the standard treatment;and a third cohort for patients who were already taking Fenofibrate (TRICOR) as a medication to treat hyperlipidemia (n=100). Most symptoms (including cough, exertional dyspnoea, SOB, sore throat, sneezing, headache, tiredness, agitation, diarrhoea, joint pain, insomnia, myalgia, and fatigue) were less prevalent for patients who administered antihyperlipidemic drugs compared to the control group. Patients who were already taking Cholesterol-lowering medication presented with symptoms varied between mild to severe. Patients on Statins or Fenofibrate also showed less tachycardia and tachypnoea compared to those who were not on antihyperlipidemic drugs, and also the need for oxygen and ICU admission were less frequent. The length of stay in hospital was shorter in patients who were already on Statins or Fenofibrate. Both Statins and Fenofibrate have improved the outcome and the severity of symptoms for patients with Covid 19 infection. Copyright © RJPT All right reserved.

3.
Tripodos ; - (52):35-50, 2022.
Artigo em Inglês | Web of Science | ID: covidwho-2206953

RESUMO

Despite the importance of mental health matters for people's well-being and the essential role of television to help spread medical issues, our study shows that the media coverage of this subject has been poor and somehow trivial during the so-called "pandemic fatigue" in Spain. This research focuses on the 24-hour television broadcast of five channels throughout 16 months, coding the content to identify trends and to know how media covered men-tal health topics all along seven days in January 2021. The analysis reveals a trivial representation of the topic, in-cluding irrelevant references to mental health that may not help make visible problems such as depression, anxiety, or stress. Instead, there seems to be a lack of rigorous analysis of the mental health conditions arising after the pan-demic. We can infer that private broad-casters have a more suitable approach when presenting data, describing people involved or taking advice from mental health professionals. Effective information on mental health requires deep messaging and medical recom-mendations or statements, but from this research, it turns out that there is a touch of frivolity in the way television approaches mental health issues.

4.
NeuroQuantology ; 20(17):1630-1635, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-2206887
5.
NeuroQuantology ; 20(17):1503-1510, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-2206885

RESUMO

Parents and students want their experiences to be life-changing. The years spent in college are often a period of learning and development for many students. But obstacles like sorrow, despair, anxiety, sadness depression, though, can stand in the way. The prevalence of anxiety and depression among college students has significantly grown since the beginning of the COVID-19 pandemic. According to a recent survey, severe depression and anxiety affect one in three college students. The early detection and treatment of depression can be aided by parents and students being aware of the risk factors and symptoms. In the present study, the validated DASS-21 scale was used as the evaluation tool. It was discovered that college students exhibit mild levels of stress, moderate levels of depression, and severe levels of anxiety. It was shown that female students were more likely than their male counterparts to experience psychological distress. Given the high prevalence of depression, anxiety, and stress among students, support services and preventive measures must be put in place to assist all students, but especially those who are more prone to experiencing greater levels of these psychological illnesses. The present article is based on the study conducted among undergraduate students in Punjab. Copyright © 2022, Anka Publishers. All rights reserved.

6.
NeuroQuantology ; 20(11):8601-8605, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-2206869

RESUMO

Introduction:The Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2), firstly known as the 2019 novel Coronavirus (2019-nCoV), started in Wuhan in China in December 2019.The World Health Organization confirmed it as a pandemic on 11th March 2020. Although this virus can cause severe respiratory failure and even death in infected patients, it has spread rapidly and continues to spread among people because it can cause mild or no symptoms in the majority of cases.2 Material(s) and Method(s):This is a prospective study in patients admitted in the isolation ward ofVinayaka Mission KirupanandaVariyar Medical College and Hospitals, Salem between January 2020 to December 2020 (1 year). There were 116 symptomatic patients out of total 181 patients diagnosed with Covid-19 From 01/01/2020 till 31/12/2020, a total of 116 respondents met inclusion. Which were COVID-19 positive symptomatic patients by testing or diagnosis by a health care practitioner in Vinayaka Mission KirupanandaVariyar Medical College and Hospitals, Salem Although most respondents experienced other major COVID-19-related symptoms during or after their chemosensory change. Result(s):Since the Covid-19 pandemic has begun, many individuals have noted many ENT manifestations along with the other general symptoms like fever (98 pt) >cough (81 pt) >weakness/fatigue (47 pt) >difficulty in breathing (22 pt) >muscle ache (14 pt) >headache (14 pt) & diarrhoea (6 pt). Among ENT manifestations throat symptoms were found most common including loss of taste in 19 pt. It was noticed that most commonly sweet and salt goes first then sour taste vanish and bitter and chilli taste goes in the end, most of them were reversible after 2-3 weeks. Among nasal symptoms nasal congestion was found most common (18 pt) followed by loss of smell (22 pt), nasal blockage (16 pt) & runny nose (12 pt). Loss of smell was also reversible in most of the cases after 2-3 weeks. Ear symptoms were not so commonly found. Although itching in bilateral ear, sensation of ear fullness, ear ache and conductive hearing loss were complained by some patients. Conclusion(s):This study represents the initial findings of a longitudinal survey of all individuals with ENT manifestations along with the chemosensory loss in the symptomatic confirmed covid-19 patients admitted in the isolation wards of Vinayaka Mission KirupanandaVariyar Medical College and Hospitals, Salem during the COVID-19 pandemic. Patients may present with smell or taste loss before other symptoms and experience complete subjective loss of smell or taste. During the ongoing COVID-19 pandemic, changes in smell or taste are not being considered indicative of possible COVID-19 infection especially in the absence of other high-suspicion symptoms. Copyright © 2022, Anka Publishers. All rights reserved.

7.
Journal of Pharmaceutical Negative Results ; 13:6157-6162, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-2206751

RESUMO

When COVID-19 vaccines got authorization for emergency administration in order to attain immunity of the population against the pandemic in India, the Government rushed the people to get vaccinated. But two years into being vaccinated with the primary doses, the efficacy of the doses decreased and infection with COVID increased. The Government of India introduced the precaution dose on 10th January, 2022, but not much vaccination turn out is observed in case of precaution dose. India is facing what is known as vaccination fatigue which is causing vaccination hesitancy. This study identified the causes of vaccination fatigue among the adult population in the state of Assam, the primary cause being pandemic fatigue. With the increase in COVID cases worldwide, The Government should implement necessary steps to conquer the vaccination fatigue and decrease the vaccination hesitancy in the state. Copyright © 2022 Wolters Kluwer Medknow Publications. All rights reserved.

8.
Perspectives in Education ; 40(4):70-88, 2022.
Artigo em Inglês | ProQuest Central | ID: covidwho-2206481

RESUMO

The transition to online learning at a time of intensive efforts to ensure that the academic project continued under the trying conditions brought on by the COVID-19 pandemic placed intense pressure on both staff and students, increasing their workload. The increased workload placed students at a risk of burnout. While most burnout research focuses on the workplace, there is growing recognition that study activities can have a similar impact on students. The study drew on the conceptualisation of various authors on burnout which is conceived as three subdomains, namely, emotional exhaustion, cynicism and feelings of low accomplishment or inefficacy. This study made use of a cross-sectional survey design. The sample for the study was drawn from students at an Open Distance e-Learning (ODeL) institution in South Africa using a census sampling approach. The findings of this study show relatively low levels of burnout and high levels of study engagement among respondents. This is despite most respondents reporting being employed while studying. Furthermore, the relationship between dropout intention and burnout was weak but significant. Further areas of research in this field could include students from contact institutions, or a focus on postgraduate students who are employed while studying or explore gender differences among students in different fields of study.

9.
Iranian Journal of Medical Sciences ; 48(1):91-97, 2023.
Artigo em Inglês | EMBASE | ID: covidwho-2205677

RESUMO

Recently, due to the coronavirus disease 2019 (COVID-19) pandemic, much concern has been raised about patients with chronic diseases who may become more susceptible to the disease. The present cross-sectional study aimed to characterize the clinical course of COVID-19 in patients with systemic lupus erythematosus (SLE). In addition, a possible correlation between the immunosuppression state and the incidence of COVID-19 is investigated. In May 2020, 500 SLE patients registered in the database of Golestan Rheumatology Research Center (Golestan province, Iran) were selected for this cross-sectional study. Using a questionnaire, patients were contacted by telephone to collect data including demographic characteristics, disease status, drug use, and new clinical symptoms. Data were analyzed using SPSS software version 24.0. Of the 500 selected patients, 355 responded to the phone calls and subsequently enrolled in the study. Among the enrolled patients, 25 were classified as COVID-19 positive, including eight hospitalized patients, of which two required intensive care and subsequently died. COVID-19 incidence was significantly lower in the immunosuppressed patients (2.2% vs. 10%, P=0.01). There was no significant correlation between hydroxychloroquine consumption and the incidence of COVID-19 in SLE patients. Fever, fatigue, dyspnea, and dry cough were the most common clinical symptoms. Our results showed that COVID-19 incidence was lower in immunosuppressed than the non-immunosuppressed SLE patients. Further studies are required to substantiate the role of immunosuppression in the development of COVID-19. A preprint version of this study was published at https://www. researchsquare.com/article/rs-78704/v1 with doi: https://doi. org/10.21203/rs.3.rs-78704/v1. Copyright © Iranian Journal of Medical Sciences.

10.
Revista Colombiana de Cardiologia ; 29(Supplement 4):47-51, 2022.
Artigo em Espanhol | EMBASE | ID: covidwho-2205344

RESUMO

A 67-years-old woman with hypertension, obesity as previous diseases, presented to the emergency department due to cough, fatigue, fever, and dyspnea. ST-segment elevation was visualized during monitoring, troponin was positive, the coronary angiography was negative;the ventriculogram and transthoracic echocardiogram documented apical akinesia. The RT-PCR was positive for SARS CoV-2;the diagnosis was takotsubo-syndrome. Copyright © 2021 Sociedad Colombiana de Cardiologia y Cirugia Cardiovascular.

11.
Clinical Social Work and Health Intervention ; 13(6):19-22, 2022.
Artigo em Inglês | ProQuest Central | ID: covidwho-2205097

RESUMO

Postcovid syndrome affects 5-20% of all patients with symptomatic Covid-I9 infection, resulting in temporary or permanent disability for next weeks or months. The commonest syndromes after long Covid-I9, (or chronic fatigue syndrome after Covid, or as synonymum postcovid syndrome) are psychic or psychosomatic disorders known under the name Depression and Anxiety Syndrome. After the unrest and armed conflicts during the Covid era, clients or patients, mainly migrants of war, are also exposed to chronic post trauma syndrome related to previous or recent struction of temporary homelesness and escape from affected regions/country. Cumulation of those 2 syndromes may have devastating consequences to both, individual health and economic losses due to permanent working and economy disabilities and consumption of health and social funds. After the unrest and armed conflicts during Covid era,clients or patients, mainly migrants of war, are also exposed to chronic post trauma syndrome related to previous or recent destruction of infrastructure, temporary homelesness and escape from affected regions/country.

12.
Asian Journal of Pharmaceutical and Clinical Research ; 15(12):114-117, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-2205058

RESUMO

Objective: Coronavirus disease of 2019 (COVID-19) is a highly transmissible and pathogenic infection caused by severe acute respiratory syndrome, which resulted in a global pandemic and a significant loss of human life. The newer variants of concern are evolving even with the broadening vaccine immunity. Much of the clinical course remains uncertain especially the possible long-term health consequences. It is observed that there is an inter-individual variability in the occurrence of these post-COVID symptoms. Method(s): A prospective observational survey was conducted to demonstrate the post-COVID-19 manifestations and to identify if there is any association of these manifestations with the disease severity and presence of comorbidities. Result(s): About 85% of our study subjects reported post-COVID manifestations of varying degrees. Fatigue was the most common post-COVID manifestation reporting to 56.36%. This was followed by body ache (43.3%) and myalgia (36.81%). The least observed manifestations were myocarditis (1.81%), heart attack (1.36%), and vomiting (1.36%). Conclusion(s): An association between the severity of COVID disease and comorbidities was identified. The surface plot graph signified the existence of a positive association between the post-COVID manifestations with the severity of disease and the presence of comorbidities. The functional outcomes of the subjects after recovery were assessed using a post-COVID functional status scale. Copyright © 2022 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

13.
Bulletin of Pharmaceutical Sciences ; Assiut. 45(2):801-809, 2022.
Artigo em Inglês | EMBASE | ID: covidwho-2204953

RESUMO

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that causes severe acute respiratory syndrome (SARS). It was discovered in December 2019 in Wuhan, China., which subsequently led to a nationwide outbreak. The World Health Organization included the AstraZeneca and Sinopharm vaccines for the WHO Emergency Use List on February 16 and May 7, 2021, respectively. Egyptians have gotten 2,623,200 doses of AstraZeneca's COVID-19 vaccination plus 500,000 doses of Sinopharm vaccine. The trial would test the vaccinations' short-term side effects on Egyptian people aged 18 and older. Result(s): Most symptoms decreased significantly after the second dose when compared to symptoms seen at the first dose .In addition, both doses reduced symptoms significantly compared to the first dose.Interestingly, the desire to sleep appears to significantly increase the side effects again after both doses when compared to the second dose alone. The majority or nearly all of the participants (96.5%) had no infection after vaccination. Conclusion(s): Mild to moderate side effects are to be expected after the vaccination process because the body's immunomodulatory instructions can lead to negative symptoms. Symptoms include injection site soreness, fever, tiredness, headache, muscle aches, chills, and diarrhoea.. The majority or nearly all of the participants (96.5%) had no infection after vaccination. Training and continuing education are needed to improve universal vaccine acceptance and reduce frequency. Copyright © 2022 Assiut University. All rights reserved.

14.
Rossiyskiy Vestnik Perinatologii i Pediatrii ; 67(5):118-122, 2022.
Artigo em Russo | EMBASE | ID: covidwho-2204918

RESUMO

The novel SARS-CoV-2 coronavirus infection is predominantly asymptomatic or presenting few symptoms in children, and life-threatening complications are rare. In most cases, symptoms of ARVI are observed, such as fever, cough, myalgia, or weakness, which are milder than in adult patients. In addition, most laboratory and radiographic findings in children with COVID-19 are nonspecific. However, some children may develop prolonged forms of COVID-19, as well as long-term symptoms (post-COVID syndrome) after the illness, which significantly affect the quality of life. There are different data regarding the prevalence and duration of long-term effects of a new coronavirus infection in children. The most common symptoms following COVID-19 in children/teens are fatigue, lack of concentration, and muscle pain. The review presents the latest literature data on the duration and course of COVID-19 in children. It should be remembered that long-term symptoms could affect the physical, social, and psychological well-being of children and adolescents in the future. Copyright © 2022 National Academy of Pediatric Science and Innovation. All rights reserved.

15.
Practice Nursing ; 34(Supp1):4-4, 2023.
Artigo em Inglês | CINAHL | ID: covidwho-2203789

RESUMO

The article discusses a study which showed that vaccine fatigue, or people's inaction on vaccine information due to perceived burden and burnout, has led to a decline in vaccination rates worldwide, and the need to use tailored communications with communities to help increase uptake.

16.
Journal of the Japanese Association for Infectious Diseases ; 96(3):65-73, 2022.
Artigo em Japonês | GIM | ID: covidwho-2203544

RESUMO

This study was aimed at monitoring the adverse reactions to tozinameran (mRNA vaccine against SARS-CoV-2) in the vaccine recipients, and to investigate factors that might affect the risk of development of these reactions. The adverse events (13 injection-site and systemic reactions) on day 1 (vaccination day), day 2, day 3, day 4, and day 5- were monitored in the employees of Fukuoka City Hospital who were vaccinated at the hospital between March 2021 and April 2021. The severities of the adverse reactions were also investigated. The frequencies of virtually all the adverse reactions were the highest on day 2, both after the first and after the second dose. The incidence of adverse reactions on day 2 after the first (and second) vaccine dose was 86.0% (86.9%) for pain at the injection site, 33.2% (76.9%) for fatigue, 14.3% (56.9%) for headache, 37.0% (57.2%) for myalgia, 5.2% (51.1%) for fever, and 9.3% (43.9%) for joint pain. The proportion of recipients with any adverse reactions on day 5- was significantly higher after the second dose than after the first dose. The incidence of moderate to severe adverse reactions (except for pain and swelling at the injection site, and rash) was also significantly higher after the second dose. Differences in the incidence of adverse reactions by sex, age, and number of doses were observed. In particular, female sex, age 55 years or under, and second vaccine dose were associated with a significantly increased incidence of fatigue and headache. Female sex and second vaccine dose were identified as being consistently associated with an increased frequency of adverse reactions. The results of the present study would be useful for predicting adverse reactions in prospective recipients, and for setting the vaccination day.

17.
Journal of Clinical and Diagnostic Research ; 17(1):OC13-OC17, 2023.
Artigo em Inglês | EMBASE | ID: covidwho-2203495

RESUMO

Introduction: Known independent predictors of extended Length Of Stay (LOS) in Coronavirus Disease 2019 (COVID-19) included older age, chronic kidney disease, elevated maximum temperature, and low minimum oxygen saturation. Additional known predictors of prolonged hospitalisation included male sex, chronic obstructive pulmonary disease, hypertension, and diabetes. Elevated levels of C-Reactive Protein (CRP), creatinine, and ferritin are proven determinants of hospitalisation and LOS. Determining predictors of LOS will aid in triaging and management of COVID-19 patients. Aim(s): To assess the clinical, biochemical and radiological profile of admitted COVID-19 patients and determine the predictors of prolonged length of stay at hospital. Material(s) and Method(s): It was a retrospective, cross-sectional observational, record-based study included hospital records of 544 confirmed COVID-19 patients, above age of 18 years admitted at Bharati Vidyapeeth Medical College and Hospital, Pune, Maharashtra, India, during February 2021 to June 2021. Possible determinants of LOS were studied including their demographic, epidemiological, clinical and radiological characteristics. The patients were divided into two groups as per median LOS i.e, group I with LOS <10 days (n=277) and group II with LOS >=10 days (n=267). Statistical analysis was done using Chi-square test, proportion test, Z test, Mann-Whitney U test, regression analysis by Statistical Package for the Social Sciences (SPSS) software version 23.0. Result(s): Mean age in group I and II was 47.83+/-16.34 years and 53.21+/-15.63 years (p-value <0.0001), respectively. The fatigue was significantly more in group II than group I (p-value=0.018). Diabetes mellitus was more (p-value=0.026) and severity of illness (p-value<0.0001) was significantly higher in group II than group I. In univariate analysis, mean Neutrophil/Lymphocyte ratio (p-value<0.0001), serum LDH (p-value<0.018), blood urea level (p-value<0.0001), random blood sugar (p-value=0.003), glycated haemoglobin (HbA1c) (p-value=0.072) and serum creatinine (p-value=0.41) were significantly more in group II. Median CRP (p-value<0.0001), D-dimer (p-value<0.0001), serum ferritin (p-value<0.0001), procalcitonin (p-value<0.0001), Serum Glutamic Oxaloacetic Transaminase (SGOT) (p-value=0.002) was significantly higher in group II. Lung involvement {chest radiograph or High-Resolution Computed Tomography (HRCT) chest} was significantly (p-value<0.0001) more in group II. Conclusion(s): Fatigue, older age, diabetes mellitus, severity of illness, mean neutrophil/lymphocyte ratio, CRP, D-dimer, serum ferritin, serum Lactate Dehydrogenase (LDH), procalcitonin, blood urea, SGOT were associated with prolonged LOS among hospitalised COVID-19 patients. Copyright © 2023 Journal of Clinical and Diagnostic Research. All rights reserved.

18.
Cureus ; 14(12):e32295, 2022.
Artigo em Inglês | EuropePMC | ID: covidwho-2203387

RESUMO

Stellate ganglion block (SGB) is gaining increasing acceptance as a treatment modality for various medical conditions. It works by blocking neuronal transmissions which in turn alleviates sympathetically-driven disease processes. Many of the prolonged sequelae of long COVID are thought to be mediated by dysregulation of the autonomic nervous system, and SGB is being investigated as a potential option for symptomatic management of long COVID. This case report demonstrates the efficacy of SGB in a previously healthy patient for the management of long COVID symptoms including fatigue, post-exertional malaise, shortness of breath, and gastrointestinal symptoms.

19.
Dicle Tip Dergisi ; 49(4):579-589, 2022.
Artigo em Inglês | ProQuest Central | ID: covidwho-2202885

RESUMO

Since the first case in Turkey was documented on March 11, 2020, the disease spread rapidly and continues to pose a public health threat in our country. Patients meeting any of the following criteria were hospitalized for inpatient treatment: - Respiratory distress, tachypnea (respiratory rate > 30/min) or oxygen saturation (SpO2) < 90% on room air, - Age > 50 years, - Comorbidity (cardiovascular disease, diabetes mellitus, hypertension, cancer, chronic lung disease, immunosuppressive conditions), - Poor prognostic markers in blood tests performed at admission (blood lymphocyte count < 800/p.L, CRP > 40 mg/L, ferritin > 500 ng/ml, or D-dimer > 1000 ng/ml), - Chest x-ray or CT findings of bilateral diffuse pneumonia. Patients were classified into four COVID-19 clinical severity groups according to the classification recommended by the World Health Organizationll: - Mild: Presenting with mild upper and lower respiratory tract symptoms but no signs of hypoxia or viral pneumonia - Moderate: Presenting with signs of pneumonia but SpO2 > 90 mmHg on room air - Severe: Presenting with clinical signs of pneumonia and severe respiratory distress or SpO2 < 90 mmHg on room air - Critical: Presenting with acute respiratory distress syndrome (ARDS) When evaluating demographic, laboratory, and clinical findings by disease severity, the patients were divided into two groups, mild+moderate (group 1) and severe+critical (group 2). Data collection Data regarding the patients' demographical, clinical, and radiological characteristics, comorbid status, laboratory findings such as serum leukocyte, neutrophil, lymphocyte, and platelet counts, biochemical and coagulation parameters, acute phase reactants, procalcitonin, troponin levels and at first admission and during follow-up (day 3, 7, and 14), symptoms at first admission, treatments, complications, and outcomes were obtained by retrospective review of electronic patient records.

20.
Studies in Communication and Media ; 11(3):477-507, 2022.
Artigo em Inglês | Scopus | ID: covidwho-2202883

RESUMO

This study investigates the comparative prevalence of information avoidance concerning the coronavirus and its relationship with media evaluation and use. We argue that information avoidance is a behavior that broadly signifies the intermittent and conscious practice of shunning specific content. It is problematic because having an informed citizenry is essential, especially during a global pandemic. Given the global affectedness of the world by the coronavirus, we believe in the necessity for international comparative research and conduct our study in Pakistan, Germany, and Indonesia. Based on the existing literature, which stems predominantly from the Global North, we assume that media use and its evaluations are associated with information avoidance and test our assumptions against cross-cultural differences. Hence, we collected data in Germany (n = 822), Indonesia (n = 1164), and Pakistan (n = 467). The results indicate important differences with regard to the prevalence of information avoidance as well as media use and its evaluations across the three countries. The analysis further confirms a rather stable relationship between media evaluations with information avoidance but revealed interesting differences in the associations between media use and avoidance. © Christina Schumann, Waqas Ejaz, Mira Rochyadi-Reetz, Eni Maryani, Anna Agustina.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA